These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 34175668)
1. Regulation of B cell functions by S-nitrosoglutathione in the EAE model. Kim J; Islam SMT; Qiao F; Singh AK; Khan M; Won J; Singh I Redox Biol; 2021 Sep; 45():102053. PubMed ID: 34175668 [TBL] [Abstract][Full Text] [Related]
2. S-nitrosoglutathione reductase (GSNOR) inhibitor as an immune modulator in experimental autoimmune encephalomyelitis. Saxena N; Won J; Choi S; Singh AK; Singh I Free Radic Biol Med; 2018 Jun; 121():57-68. PubMed ID: 29694854 [TBL] [Abstract][Full Text] [Related]
3. Regulation of IL-10 and IL-17 mediated experimental autoimmune encephalomyelitis by S-nitrosoglutathione. Singh I; Nath N; Saxena N; Singh AK; Won JS Immunobiology; 2018 Oct; 223(10):549-554. PubMed ID: 29960806 [TBL] [Abstract][Full Text] [Related]
4. O-Aminobenzoyl-S-nitrosoglutathione: A fluorogenic, cell permeable, pseudo-substrate for S-nitrosoglutathione reductase. Sun BL; Palmer L; Alam SR; Adekoya I; Brown-Steinke K; Periasamy A; Mutus B Free Radic Biol Med; 2017 Jul; 108():445-451. PubMed ID: 28419866 [TBL] [Abstract][Full Text] [Related]
5. Pharmacologic inhibition of S-nitrosoglutathione reductase protects against experimental asthma in BALB/c mice through attenuation of both bronchoconstriction and inflammation. Blonder JP; Mutka SC; Sun X; Qiu J; Green LH; Mehra NK; Boyanapalli R; Suniga M; Look K; Delany C; Richards JP; Looker D; Scoggin C; Rosenthal GJ BMC Pulm Med; 2014 Jan; 14():3. PubMed ID: 24405692 [TBL] [Abstract][Full Text] [Related]
6. Efficacies of S-nitrosoglutathione (GSNO) and GSNO reductase inhibitor in SARS-CoV-2 spike protein induced acute lung disease in mice. Kim J; Qiao F; Singh AK; Won J; Singh I Front Pharmacol; 2023; 14():1304697. PubMed ID: 38143504 [TBL] [Abstract][Full Text] [Related]
8. Targeting GSNOR for functional recovery in a middle-aged mouse model of stroke. Khan M; Kumar P; Qiao F; Islam SMT; Singh AK; Won JS; Feng W; Singh I Brain Res; 2020 Aug; 1741():146879. PubMed ID: 32418890 [TBL] [Abstract][Full Text] [Related]
9. Mechanism of inhibition for N6022, a first-in-class drug targeting S-nitrosoglutathione reductase. Green LS; Chun LE; Patton AK; Sun X; Rosenthal GJ; Richards JP Biochemistry; 2012 Mar; 51(10):2157-68. PubMed ID: 22335564 [TBL] [Abstract][Full Text] [Related]
10. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis. Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651 [TBL] [Abstract][Full Text] [Related]
11. Discovery of s-nitrosoglutathione reductase inhibitors: potential agents for the treatment of asthma and other inflammatory diseases. Sun X; Wasley JW; Qiu J; Blonder JP; Stout AM; Green LS; Strong SA; Colagiovanni DB; Richards JP; Mutka SC; Chun L; Rosenthal GJ ACS Med Chem Lett; 2011 May; 2(5):402-6. PubMed ID: 24900320 [TBL] [Abstract][Full Text] [Related]
12. Effect of the S-nitrosoglutathione reductase inhibitor N6022 on bronchial hyperreactivity in asthma. Que LG; Yang Z; Lugogo NL; Katial RK; Shoemaker SA; Troha JM; Rodman DM; Tighe RM; Kraft M Immun Inflamm Dis; 2018 Jun; 6(2):322-331. PubMed ID: 29642282 [TBL] [Abstract][Full Text] [Related]
13. Human mesenchymal stem cells upregulate CD1dCD5(+) regulatory B cells in experimental autoimmune encephalomyelitis. Guo Y; Chan KH; Lai WH; Siu CW; Kwan SC; Tse HF; Wing-Lok Ho P; Wing-Man Ho J Neuroimmunomodulation; 2013; 20(5):294-303. PubMed ID: 23899693 [TBL] [Abstract][Full Text] [Related]
14. Regulatory T Cells and Their Derived Cytokine, Interleukin-35, Reduce Pain in Experimental Autoimmune Encephalomyelitis. Duffy SS; Keating BA; Perera CJ; Lees JG; Tonkin RS; Makker PGS; Carrive P; Butovsky O; Moalem-Taylor G J Neurosci; 2019 Mar; 39(12):2326-2346. PubMed ID: 30651334 [TBL] [Abstract][Full Text] [Related]
16. IL-10 mediates resistance to adoptive transfer experimental autoimmune encephalomyelitis in MyD88(-/-) mice. Cohen SJ; Cohen IR; Nussbaum G J Immunol; 2010 Jan; 184(1):212-21. PubMed ID: 19949074 [TBL] [Abstract][Full Text] [Related]
17. CXCR3 signaling in glial cells ameliorates experimental autoimmune encephalomyelitis by restraining the generation of a pro-Th17 cytokine milieu and reducing CNS-infiltrating Th17 cells. Chung CY; Liao F J Neuroinflammation; 2016 Apr; 13(1):76. PubMed ID: 27068264 [TBL] [Abstract][Full Text] [Related]
18. Augmentation of S-Nitrosoglutathione Controls Cigarette Smoke-Induced Inflammatory-Oxidative Stress and Chronic Obstructive Pulmonary Disease-Emphysema Pathogenesis by Restoring Cystic Fibrosis Transmembrane Conductance Regulator Function. Bodas M; Silverberg D; Walworth K; Brucia K; Vij N Antioxid Redox Signal; 2017 Sep; 27(7):433-451. PubMed ID: 28006950 [TBL] [Abstract][Full Text] [Related]
19. Host T cells are the main producers of IL-17 within the central nervous system during initiation of experimental autoimmune encephalomyelitis induced by adoptive transfer of Th1 cell lines. Lees JR; Iwakura Y; Russell JH J Immunol; 2008 Jun; 180(12):8066-72. PubMed ID: 18523270 [TBL] [Abstract][Full Text] [Related]
20. [Therapeutic Effect of SPK1 Gene Transfected Adipose Derived Mesenchymal Stem Cells on Experimental Autoimmune Encephalomyelitis Mice and Its Effect on T Helper Cell 17/Regulatory T Cells Balance]. Zhou T; Xu CP; Xiao Y; Zhang Q; Li L Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Dec; 42(6):755-765. PubMed ID: 33423722 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]